Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCL #lymphoma #lymsm https://t.co/O2faHlnH6L
2,454 followers
1,384 followers
Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCL by Nikeshan Jeyakumar https://t.co/KjeB49bcvU
925 followers
New article: Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCL https://t.co/TaaSvWEh8S #DLBCL #lymsm #hematology https://t.co/rVSuXzIZNF
18,077 followers
Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCL: Cellular therapies have transformed the treatment of relapsed/refractory diffuse large B-cell, #immunology… https://t.co/x9tdy